# Vitara Biomedical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/vitara-biomedical

- Industry: Medical Devices & Equipment
- Headquarters: Philadelphia, US
- Website: www.vitara.com
- Total disclosed funding: $10M
- Latest round: Series A (Oct 11, 2024)
- Investors on record: 5

## About

Based in Pennsylvania, US, and founded in 2019, Vitara Biomedical, Inc. develops therapeutic medical devices for premature infants and provides physiological procedures for neonatal care for newborns to help lower mortality and comorbidities. In November 2024, Vitara Biomedical, Inc. raised USD 50 million in series B funding led by new investor Sands Capital Ventures, with participation from other new investors GV, First Spark Ventures, Khosla Ventures, and Flerie Invest.

The company is developing a therapeutic platform for premature infants that is inspired by natural physiological processes and has the potential to transform neonatal care.

The organization plans to use the July 2022 funding to advance its artificial womb technology for premature babies.

The organization plans to use the November 2024 funding to advance its efforts toward a first-in-human clinical study of its technology.

## Funding rounds

- Series A, Oct 11, 2024, $10M — Khosla Ventures, GV, Sands Capital Alternatives, Flerie Invest, First Spark Ventures

## Investors

- Khosla Ventures (https://capitalatlas.ai/funds/khosla-ventures) — Series A
- GV (https://capitalatlas.ai/funds/gv) — Series A
- Sands Capital Alternatives (https://capitalatlas.ai/funds/sands-capital-alternatives) — Series A
- Flerie Invest (https://capitalatlas.ai/funds/flerie-invest) — Series A
- First Spark Ventures (https://capitalatlas.ai/funds/first-spark-ventures) — Series A